Psoriasis is a clinically heterogeneous lifelong skin disease that presents in multiple forms
such as plaque, flexural, guttate, pustular or erythrodermic. An estimated 60 million people …

In the last decades, autoimmune diseases have experienced a dramatic increase in Western
countries. The involvement of environmental factors is strongly suspected to explain this rise …

Incidence of IBD is rising in parallel with overweight and obesity. Contrary to conventional
belief, about 15–40% of patients with IBD are obese, which might contribute to the …

Psoriasis is a systemic, immune‐mediated disorder, characterized by inflammatory skin and
joint manifestations. A range of co‐morbidities is associated with psoriasis, including …

As summarized in the first article in this continuing medical education series, the currently
available epidemiologic data suggest that psoriasis may be a risk factor for cardiometabolic …

Hidradenitis suppurativa (HS) is a chronic, inflammatory, debilitating skin disease. The aim
of the study was to systematically review the literature and critically answer the question: In …

Background The efficacy of biological therapies used for the treatment of chronic plaque
psoriasis can be influenced by numerous variables including body mass index (BMI) …

Inflammatory bowel diseases (IBD) affect the gastrointestinal tract: they include Crohn's
disease (CD) and ulcerative colitis (UC). Each has a different phenotypic spectrum …

Obesity, particularly abdominal obesity, is currently considered a chronic low-grade
inflammatory condition that plays an active role in the development of the pathophysiologic …

Background: Obesity has long been associated with psoriasis and it is considered to be an
independent risk factor for chronic heart diseases in these patients. Recently, some of the …